Sasagu Kurozumi
3718511, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 73 publications
Early diagnosis of capivasertib-associated severe hyperglycemia with diabetic ketosis diagnosed in routine clinical practice: a case report with review of literature.
Journal: Endocrine journal
Published: July 01, 2026
A transcriptional ILCness score reveals lobular-like biology and clinical behavior beyond CDH1 mutation status.
Journal: Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc
Published: May 23, 2026
Abemaciclib rechallenge after progression on abemaciclib plus endocrine therapy in patients with hormone receptor-positive HER2-negative metastatic breast cancer: results from the phase II again study (WJOG14220B).
Journal: Breast cancer research and treatment
Published: March 30, 2026
Changes in CD8-positive lymphocytes following chemotherapy with concomitant bevacizumab in HER2-negative breast cancer.
Journal: Breast cancer (Tokyo, Japan)
Published: November 26, 2025
Efficacy of xeno-free induced mesenchymal stem/stromal cells in enhancing autologous fat graft survival.
Journal: Breast cancer (Tokyo, Japan)
Published: July 20, 2025
Molecular and Biological Features of Invasive Lobular Carcinoma: Toward New Treatment Strategies.
Journal: Annals of surgical oncology
Published: March 06, 2025
Clinical Significance of FAM83G in Breast Cancer: Association With Triple-negative Subtype and Prognosis.
Journal: Anticancer research
Published: September 19, 2024
Research on biomarkers using innovative artificial intelligence systems in breast cancer.
Journal: International journal of clinical oncology
Published: June 28, 2024
Significance of MUC1 and β-Catenin Localization in Mucinous Carcinoma of the Breast.
Journal: Anticancer research
Published: March 02, 2024
Identification of MicroRNAs Associated with Histological Grade in Early-Stage Invasive Breast Cancer.
Journal: International journal of molecular sciences
Published: November 23, 2023
Utility of human epidermal growth factor 2 heterogeneity as a prognostic factor in triple-negative breast cancer.
Journal: Medical molecular morphology
Published: November 10, 2023
Cancer-associated fibroblast spatial heterogeneity and EMILIN1 expression in the tumor microenvironment modulate TGF-β activity and CD8+ T-cell infiltration in breast cancer.
Journal: Theranostics
Published: September 29, 2023
Last Updated: 09/26/2026